← Back to Search

CGM Arm for Type 2 Diabetes (IMPaCT2 Trial)

N/A
Waitlist Available
Led By Risa M Wolf, MD
Research Sponsored by Johns Hopkins University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Type 2 diabetes, diabetes duration >3 months
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 3 - 6 months
Awards & highlights

IMPaCT2 Trial Summary

This study is evaluating whether a continuous glucose monitor may help improve glucose control in children with type 2 diabetes.

Eligible Conditions
  • Type 2 Diabetes

IMPaCT2 Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

IMPaCT2 Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 3 - 6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 3 - 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Hemoglobin A1c
More Frequent Glycemic Control Monitoring
More Frequent Insulin Administration
+1 more

Side effects data

From 2009 Phase 3 trial • 451 Patients • NCT00406133
11%
Severe Hypoglycemia
100%
80%
60%
40%
20%
0%
Study treatment Arm
Secondary Cohort Control Group
Primary Cohort RT-CGM Group
Primary Cohort Control Group
Secondary Cohort RT-CGM Group

IMPaCT2 Trial Design

1Treatment groups
Experimental Treatment
Group I: CGM ArmExperimental Treatment1 Intervention
Children with type 2 diabetes will wear a continuous glucose monitor for 10 days.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Continuous glucose monitor
2006
Completed Phase 3
~640

Find a Location

Who is running the clinical trial?

Johns Hopkins UniversityLead Sponsor
2,262 Previous Clinical Trials
14,823,123 Total Patients Enrolled
Risa M Wolf, MDPrincipal InvestigatorJohns Hopkins School of Medicine
1 Previous Clinical Trials
500 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
CGM Use in Children With Type 2 Diabetes
2021. "CGM Use in Children With Type 2 Diabetes". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04721158.
~10 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top